Another four biotechs scratch out the first number and ask for more as IPO boom continues
Four more biotechs are raising their offers in an already record year for biotech IPOs.
Softbank-backed Relay Therapeutics scratched out its original $200 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
